MedPath

Evaluation of the Strategy of "One-stop" Endovascular Treatment for Concomitant Coronary Artery Disease and Aortic Atherosclerotic Disease

Phase 4
Conditions
Coronary Artery Disease
Aortic Atherosclerotic Disease
Interventions
Procedure: One-stop strategy group
Registration Number
NCT03563768
Lead Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Brief Summary

The study is a prospective, randomized, controlled, exploratory trail to evaluate the strategy of "one-stop" endovascular treatment for concomitant coronary artery disease and aortic atherosclerotic disease.

Detailed Description

60 patients will be allocated randomly in a 1:1 ratio into one-stop strategy group or staging strategy group. In one-stop strategy group, percutaneous coronary intervention (PCI) will be performed on the same operating room immediately after the endovascular aortic repair (EVAR); In staging strategy group, PCI will be performed several days after EVAR. The safety and effectiveness will be assessed between two groups 1 year after the operation. The economic index will be evaluated as well as.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Aged from 18 years to 75years, male or female;
  • Aortic atherosclerotic disease with indication of EVAR;
  • Coronary heart disease with indication of PCI;
  • Provided informed consent.
Exclusion Criteria
  • Acute aortic dissection
  • Acute coronary syndrome
  • Dysfunction of coagulation system
  • Patients with gastrointestinal hemorrhage
  • Known allergy to contrasts or antiplatelet drugs
  • Renal dysfunction (GFR≤60ml/min)
  • Patient with multi-branch coronary preferred CABG

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
One-stop strategy groupOne-stop strategy groupPercutaneous coronary intervention (PCI) will be performed on the same operating table immediately after the endovascular aortic repair (EVAR)
Primary Outcome Measures
NameTimeMethod
Perioperative major bleeding (BARC≥3 grade)12 months
Secondary Outcome Measures
NameTimeMethod
Difference of incidence of bleeding events (BARC 2 grade) between two groups12 months
Difference of incidence of all-cause death between two groups12 months
Difference of incidence of myocardial infarction between two groups12 months
Difference of operative success rate between two groups12 months
Difference of incidence of Stent thrombosis between two groups12 months
Composite of average in-patient time and average cost during hospitalization12 months
Difference of incidence of rupture of aorta between two groups12 months
Difference of incidence of pseudoaneurysm between two groups12 months

Trial Locations

Locations (1)

Chinese Academy of Medical Sciences, Fuwai Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath